Chengcheng Liu
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
First-line anlotinib versus bevacizumab plus CapeOX in RAS/BRAF wild-type unresectable metastatic colorectal cancer (ANCHOR): a multicenter, prospective, randomized, phase 3 trial.
Journal: Signal transduction and targeted therapy
Published: December 10, 2025
Fecal immunochemical test surveillance in colorectal cancer following adenoma resection: A longitudinal, population-based linked cohort study in China.
Journal: PLoS medicine
Published: July 17, 2024
Hepatic steatosis predicts metachronous liver metastasis in colorectal cancer patients: a nested case-control study and systematic review.
Journal: American journal of cancer research
Published: January 04, 2024
Front-line therapy for brain metastases and non-brain metastases in advanced epidermal growth factor receptor-mutated non-small cell lung cancer: a network meta-analysis.
Journal: Chinese medical journal
Published: May 10, 2023
A Randomized Phase III Study of Anlotinib Versus Bevacizumab in Combination With CAPEOX as First-Line Therapy for RAS/BRAF Wild-Type Metastatic Colorectal Cancer: A Clinical Trial Protocol.
Journal: Technology in cancer research & treatment
Published: February 02, 2023
Comparison of Colonoscopy, Fecal Immunochemical Test, and Risk-Adapted Approach in a Colorectal Cancer Screening Trial (TARGET-C).
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: June 23, 2022
Accelerating the integration of China into the global development of innovative anticancer drugs.
Journal: The Lancet. Oncology
Published: May 06, 2022
The chromosome-scale genome of Phoebe bournei reveals contrasting fates of terpene synthase (TPS)-a and TPS-b subfamilies.
Journal: Plant communications
Published: February 16, 2022
Efficacy of first-line treatments in the elderly and non-elderly patients with advanced epidermal growth factor receptor mutated, non-small cell lung cancer: a network meta-analysis.
Journal: BMC cancer
Published: January 23, 2022
Cost-effectiveness of risk-tailored screening strategy for colorectal cancer: A systematic review.
Journal: Journal of gastroenterology and hepatology
Published: December 05, 2021
Front-Line Therapy in EGFR Exon 19 Deletion and 21 Leu858Arg Mutations in Advanced Non-Small Cell Lung Cancer: A Network Meta-Analysis.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: June 29, 2021
Optimizing Positivity Thresholds for a Risk-Adapted Screening Strategy in Colorectal Cancer Screening.
Journal: Clinical and translational gastroenterology
Published: January 12, 2021
Last Updated: 09/26/2026